The primary aim of this study is to quantify the relative effectiveness of MDA and fMDA with DHAp against no mass treatment (standard of care) for reducing Plasmodium falciparum prevalence and incidence. Strengths of this trial include: a robust study design (CRCT); cross-sectional parasite surveys as well as a longitudinal cohort; and stratification of high and low transmission areas. Primary limitations include: statistical power to detect only a 50 % reduction in primary outcomes within high and low transmission strata; potential for contamination; and potential for misclassification of exposure.
When improved through comprehensive parasitologically confirmed case reporting, HMIS data can become a valuable tool for evaluating malaria program scale-up. Using this approach, this article provides further evidence that increased ITN coverage is associated with decreased malaria morbidity and use of health services for malaria illness in Zambia.
Author: Bennett A, Eisele TP, Hamainza B, Ingwe MM, Kamuliwo M, Keating J, Miller JM, Moonga HB, Smith TA, Steketee R, Vounatsou P, Yukich J
Publication date: November 2014
Source: Population health metrics
A commentary highlighting the benefits and value for money that behaviour change communication brings to all aspects of malaria control, and discussing areas of operations research needed as transmission dynamics change.